ArticlePolymers2025
In Situ Synthesis of Non-Cytotoxic Tellurium Nanoparticle and Methacrylate Photopolymer Resin Composite with Antibacterial Activity.
Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A Composite Based onPolymers · 2026Article
- Advanced additive manufacturing in orthopedics: a comprehensive review of biomaterials, structural design, biological functions and clinical technology applications.RSC advances · 2026Review
- Tuning Ag/Co Metal Ion Composition to Control In Situ Nanoparticle Formation, Photochemical Behavior, and Magnetic-Dielectric Properties of UV-Cured Epoxy Diacrylate Nanocomposites.Nanomaterials (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Methacrylate photopolymer resin (MPR) is widely used in various fields, including the biomedical field. There are several problems associated with their use: the potential toxicity of monomer residues during incomplete polymerization and the possibility of bacterial expansion. Doping polymers with nanoparticles is one of the ways to increase the degree of polymerization (protection from toxicity), improve the performance characteristics of the polymer, and add antibacterial properties. We used an in situ polymerization method to obtain the composites of MPR with tellurium nanoparticles (TeNPs) with a dopant concentration of 0.001, 0.01, or 0.1% (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.